Another St. Louis jury just slapped Johnson & Johnson with a $55 million verdict in a baby powder lawsuit filed by a woman claiming she developed ovarian cancer after using talc-powder products for feminine hygiene for decades.

The jury concluded that the company knew that talc posed a serious health risk but failed to warn consumers.

This verdict comes on the heels of a February verdict, where another Missouri jury handed down a $75 million verdict in the first award against Johnson & Johnson over baby powder’s alleged connection to ovarian cancer.

Monday’s baby powder cancerverdict was reached following a three-week trial in a Missouri state court and consists of $5 million in compensatory damages and $50 million in punitive damages.

Plaintiff Gloria R.’s baby powder cancer lawsuit marks the second time in a row a jury has sided with the plaintiff over Johnson & Johnson, with nearly 1,200 similar lawsuits pending accusing the company of not adequately warning consumers about its talc-based baby powder products’ ovarian cancer risks.

Gloria argued that J&J continued to use talcum powder in its popular Baby Powder and Shower To Shower Powder even after it began to replace talc with cornstarch powder in other products, and that the company specifically marketed talc-based baby powder to the African-American and Hispanic communities.

Johnson & Johnson denied that its talcum powder products caused Gloria’s ovarian cancer and argued throughout the trial that the FDA held hearings in the 1990s on the risks of talc and determined there was no conclusive link between baby powder use and ovarian cancer.

Imerys Talc America, which is the only company that provides talc to J&J, and was also a defendant in the baby powder cancer lawsuit, was cleared of all liability.

Gloria’s cancer is currently in remission after she underwent a full hysterectomy.

A Johnson & Johnson spokeswoman wrote in an email that the company planned to appeal the verdict.

“Unfortunately, the jury’s decision goes against 30 years of studies by medical experts around the world that continue to support the safety of cosmetic talc,” stated J&J spokeswoman Carol Goodrich. “We understand that women and families affected by ovarian cancer are searching for answers, and we deeply sympathize with all who have been affected by this devastating disease with no known cause.”

Baby Powder Cancer Litigation

Plaintiffs involved in baby powder cancer litigation have accused Johnson & Johnson of failing to warn that talcum powder was linked to an increased risk for ovarian cancer for years. J&J has continually asserted that it acted properly in developing and marketing the talcum powder products.

Gloria’s baby powder cancer verdict follows a $72 million jury award from the same court in February to the family of a woman who died from ovarian cancer after years of using baby powder for feminine hygiene.

The only other baby powder cancer lawsuit to be tried resulted in a mixed verdict in a South Dakota federal court in 2013. While those jurors found J&J was negligent, they awarded no damages to the plaintiff, whose ovarian cancer was in remission at the time of the trial.

The next baby powder ovarian cancer lawsuit is slated for a September trial date in Missouri state court.

The Baby Powder Cancer Lawsuit is Case No. 1422-CC09012 in the Circuit Court of the City of St. Louis in Missouri.